Pathogenic variants in RNPC3 are associated with hypopituitarism and primary ovarian insufficiency.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
02 2022
Historique:
received: 10 04 2021
revised: 15 07 2021
accepted: 27 09 2021
pubmed: 16 12 2021
medline: 23 3 2022
entrez: 15 12 2021
Statut: ppublish

Résumé

We aimed to investigate the molecular basis underlying a novel phenotype including hypopituitarism associated with primary ovarian insufficiency. We used next-generation sequencing to identify variants in all pedigrees. Expression of Rnpc3/RNPC3 was analyzed by in situ hybridization on murine/human embryonic sections. CRISPR/Cas9 was used to generate mice carrying the p.Leu483Phe pathogenic variant in the conserved murine Rnpc3 RRM2 domain. We described 15 patients from 9 pedigrees with biallelic pathogenic variants in RNPC3, encoding a specific protein component of the minor spliceosome, which is associated with a hypopituitary phenotype, including severe growth hormone (GH) deficiency, hypoprolactinemia, variable thyrotropin (also known as thyroid-stimulating hormone) deficiency, and anterior pituitary hypoplasia. Primary ovarian insufficiency was diagnosed in 8 of 9 affected females, whereas males had normal gonadal function. In addition, 2 affected males displayed normal growth when off GH treatment despite severe biochemical GH deficiency. In both mouse and human embryos, Rnpc3/RNPC3 was expressed in the developing forebrain, including the hypothalamus and Rathke's pouch. Female Rnpc3 mutant mice displayed a reduction in pituitary GH content but with no reproductive impairment in young mice. Male mice exhibited no obvious phenotype. Our findings suggest novel insights into the role of RNPC3 in female-specific gonadal function and emphasize a critical role for the minor spliceosome in pituitary and ovarian development and function.

Identifiants

pubmed: 34906446
pii: S1098-3600(21)05347-8
doi: 10.1016/j.gim.2021.09.019
pmc: PMC7612377
mid: EMS142040
pii:
doi:

Substances chimiques

Nuclear Proteins 0
RNA-Binding Proteins 0
RNPC3 protein, human 0
Prolactin 9002-62-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

384-397

Subventions

Organisme : Cancer Research UK
ID : FC001107
Pays : United Kingdom
Organisme : Medical Research Council
ID : FC001107
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : FC001107
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 216362/Z/19/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : FC001107
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R006237/1
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-099-0002-RG-UCLIC
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 209328/Z/17/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2021 American College of Medical Genetics and Genomics. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest All authors declare that they have no conflicts of interest.

Références

Trends Endocrinol Metab. 2018 Nov;29(11):795-807
pubmed: 30078697
Endocr Rev. 2016 Dec;37(6):609-635
pubmed: 27690531
Am J Med Genet A. 2020 Aug;182(8):1952-1956
pubmed: 32462814
Ann Neurol. 2017 Jan;81(1):68-78
pubmed: 27863452
Hum Mutat. 2009 Feb;30(2):158-69
pubmed: 18726931
Brain. 2015 Aug;138(Pt 8):2161-72
pubmed: 26072516
J Clin Invest. 2015 Nov 2;125(11):4295-304
pubmed: 26485283
Clin Sci (Lond). 2016 Mar;130(6):421-32
pubmed: 26846580
N Engl J Med. 2014 Mar 6;370(10):972-4
pubmed: 24597873
Am J Hum Genet. 2014 Dec 4;95(6):754-62
pubmed: 25480036
Am J Hum Genet. 2013 Apr 4;92(4):605-13
pubmed: 23541340
Mol Genet Genomic Med. 2018 Mar;6(2):276-281
pubmed: 29363275
Hum Reprod Update. 2015 Nov-Dec;21(6):787-808
pubmed: 26243799
Am J Med Genet A. 2021 Jun;185(6):1836-1840
pubmed: 33650182
RNA Biol. 2014;11(11):1325-9
pubmed: 25692230
EMBO Mol Med. 2018 Jul;10(7):
pubmed: 29866761
Eur J Hum Genet. 2016 Jan;24(1):135-8
pubmed: 26059840
J Clin Endocrinol Metab. 2013 Sep;98(9):E1534-9
pubmed: 23902945
J Clin Invest. 2015 Jan;125(1):258-62
pubmed: 25437880
Trends Genet. 2012 Apr;28(4):147-54
pubmed: 22397991
EMBO Mol Med. 2014 Mar;6(3):299-306
pubmed: 24480542
Wiley Interdiscip Rev RNA. 2013 Jan-Feb;4(1):61-76
pubmed: 23074130
Nucleic Acids Res. 2007;35(6):1833-41
pubmed: 17332017
Cold Spring Harb Perspect Biol. 2011 Oct 01;3(10):a002675
pubmed: 21730045
Cell Stress. 2018 Feb 22;2(3):40-54
pubmed: 31225466
RNA. 2018 Mar;24(3):396-409
pubmed: 29255062
Semin Cell Dev Biol. 2018 Jul;79:103-112
pubmed: 28965864
N Engl J Med. 2014 Mar 6;370(10):943-949
pubmed: 24597867
J Clin Endocrinol Metab. 2014 Oct;99(10):E2129-32
pubmed: 25062452
Nucleic Acids Res. 2011 Oct;39(19):8531-43
pubmed: 21737423
EMBO J. 2002 Jul 15;21(14):3804-15
pubmed: 12110592
Biochem Genet. 2003 Oct;41(9-10):315-23
pubmed: 14974681
Am J Hum Genet. 2003 May;72(5):1293-9
pubmed: 12690580
Hum Mol Genet. 2011 Feb 15;20(4):641-8
pubmed: 21098506

Auteurs

Leyla Akin (L)

Department of Paediatric Endocrinology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey; Department of Paediatric Endocrinology, Faculty of Medicine, Erciyes University, Kayseri, Turkey. Electronic address: leylabakin@gmail.com.

Karine Rizzoti (K)

Stem Cell Biology and Developmental Genetics Lab, The Francis Crick Institute, London, United Kingdom.

Louise C Gregory (LC)

Genetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.

Beatriz Corredor (B)

Departments of Paediatrics and Paediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

Polona Le Quesne Stabej (P)

GOSgene, Genetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom; Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.

Hywel Williams (H)

Division of Cancer and Genetics, Genetics and Genomic Medicine, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Federica Buonocore (F)

Genetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.

Stephane Mouilleron (S)

Structural Biology Science Technology Platforms, The Francis Crick Institute, London, United Kingdom.

Valeria Capra (V)

Unit of Medical Genetics, IRCCS Giannina Gaslini Institute, Genova, Italy.

Sinead M McGlacken-Byrne (SM)

Genetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.

Gabriel Á Martos-Moreno (GÁ)

Departments of Paediatrics and Paediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain; Department of Paediatrics, Universidad Autónoma de Madrid, Madrid, Spain; CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.

Dimitar N Azmanov (DN)

Centre of Medical Research, The University of Western Australia and Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia; Department of Diagnostic Genomics, PathWest, QEII MedicalCentre, Perth, Western Australia, Australia.

Mustafa Kendirci (M)

Department of Paediatric Endocrinology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.

Selim Kurtoglu (S)

Department of Paediatric Endocrinology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.

Jenifer P Suntharalingham (JP)

Genetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.

Christophe Galichet (C)

Stem Cell Biology and Developmental Genetics Lab, The Francis Crick Institute, London, United Kingdom.

Stefano Gustincich (S)

Istituto Italiano di Tecnologia - IIT, Genova, Italy.

Velibor Tasic (V)

University Children's Hospital, Medical School, Skopje, North Macedonia.

John C Achermann (JC)

Genetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.

Andrea Accogli (A)

Division of Medical Genetics, Department of Specialized Medicine, Montreal Children's Hospital, McGill University Health Centre (MUHC), Montreal, QC, Canada; Department of Human Genetics, McGill University, Montreal, QC, Canada.

Aleksandra Filipovska (A)

Centre of Medical Research, The University of Western Australia and Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia; Telethon Kids Institute, Perth Children's Hospital, Nedlands, Western Australia, Australia.

Anatoly Tuilpakov (A)

Department of Endocrine Genetics, Research Centre for Medical Genetics, Moscow, Russia; Department of Inherited Endocrine Disorders, Endocrinology Research Centre, Moscow, Russia.

Mohamad Maghnie (M)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy; Department of Paediatrics, IRCCS Giannina Gaslini Institute, Genoa, Italy.

Zoran Gucev (Z)

University Children's Hospital, Medical School, Skopje, North Macedonia.

Zeynep Burcin Gonen (ZB)

Oral and Maxillofacial Surgery, Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.

Luis A Pérez-Jurado (LA)

Genetics Unit, Universitat Pompeu Fabra, Hospital del Mar Research Institute (IMIM) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain; South Australian Health and Medical Research Institute (SAHMRI), The University of Adelaide, Adelaide, South Australia, Australia.

Iain Robinson (I)

Stem Cell Biology and Developmental Genetics Lab, The Francis Crick Institute, London, United Kingdom.

Robin Lovell-Badge (R)

Stem Cell Biology and Developmental Genetics Lab, The Francis Crick Institute, London, United Kingdom.

Jesús Argente (J)

Departments of Paediatrics and Paediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain; Department of Paediatrics, Universidad Autónoma de Madrid, Madrid, Spain; CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain; IMDEA Food Institute, Campus of International Excellence UAM+CSIC, Madrid, Spain.

Mehul T Dattani (MT)

Genetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom; South Australian Health and Medical Research Institute (SAHMRI), The University of Adelaide, Adelaide, South Australia, Australia; Department of Paediatric Endocrinology, Great Ormond Street Hospital for Children, London, United Kingdom. Electronic address: m.dattani@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH